Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ATP10B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
mRNA | LRG1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | KIF1C | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
mRNA | KDM3A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | SWAP70 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
mRNA | ALDH3B1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
mRNA | PQLC3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
mRNA | SENP7 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | ITPR2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
mRNA | FKBP2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |